Detalhe da pesquisa
1.
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
Br J Haematol
; 204(3): 839-848, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38009548